A direct comparison of effect sizes from the clinical global impression‐improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder
- 3 November 2008
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 24 (1) , 35-40
Abstract
Objective: The clinical global impression‐improvement scale (CGI‐I) is used to monitor treatment outcome in mental disorders. To better understand the properties of the CGI‐I scale in social anxiety disorder, effects sizes from the CGI‐I scale were compared to comparably calculated effect sizes from other rating scales obtained from double‐blind, placebo‐controlled trials of selective‐serotonin reuptake inhibitors in social anxiety disorder. From peer‐reviewed, double‐blind, placebo‐controlled studies evaluating selective serotonin reuptake inhibitors in social anxiety disorder, we extracted CGI‐I data and scores from other assessment scales of severity and function. Using calculations that enabled direct comparisons, effect sizes for the binarily reported CGI‐I scores were compared to effect sizes from the quantitative scales.Results: Effect sizes for the binary CGI‐I scale were statistically indistinguishable from effect sizes obtained from the other scales, with the exception of the social avoidance and distress scale.Conclusions: The CGI‐I scale is an appropriate method of assessing clinical change in trials of social anxiety disorder. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled studyInternational Journal of Neuropsychopharmacology, 2006
- Escitalopram in the treatment of social anxiety disorderThe British Journal of Psychiatry, 2005
- Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity DisorderJournal of Child and Adolescent Psychopharmacology, 2004
- Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorderHuman Psychopharmacology: Clinical and Experimental, 2004
- A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety DisorderJournal of Clinical Psychopharmacology, 2004
- Efficacy of Sertraline in Severe Generalized Social Anxiety DisorderThe Journal of Clinical Psychiatry, 2003
- Paroxetine in social phobia/social anxiety disorderThe British Journal of Psychiatry, 1999
- The measurement of disabilityInternational Clinical Psychopharmacology, 1996
- "Clinical Global Impressions"(ECDEU): Some Critical CommentsPharmacopsychiatry, 1992
- Measurement of social-evaluative anxiety.Journal of Consulting and Clinical Psychology, 1969